Dominick Colangelo Insider Trading $GENE OSCIENT PHARMACEUTICALS CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Dominick Colangelo.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Dominick Colangelo. Dominick Colangelo is EVP Corporate Dev & Operations in OSCIENT PHARMACEUTICALS CORP ($GENE) and SVP Corporate Dev & Operations in OSCIENT PHARMACEUTICALS CORP ($GENE) and President and CEO in Vericel Corp ($ASTM) and Director in Trevi Therapeutics, Inc. ($TRVI).
Dominick Colangelo in OSCIENT PHARMACEUTICALS CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Dominick Colangelo: EVP Corporate Dev & Operations, SVP Corporate Dev & Operations
Holdings: 46,469 shares
Current Value: $52,510
Latest Transaction: Mar 13 2008
$GENE Market Capitalization: $13.04M
$GENE Previous Close: $1.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Dominick Colangelo in OSCIENT PHARMACEUTICALS CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GENE, TRVI, ASTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 2008 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | EVP Corporate Dev & ... | Option Exercise | A | 2.16 | 36,629 | 79,119 | 36,629 | |
| Mar 13 2008 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | EVP Corporate Dev & ... | Grant | A | 0.00 | 14,672 | 0 | 46,469 | 31.8 K to 46.5 K (+46.14 %) |
| Feb 12 2008 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | EVP Corporate Dev & ... | Buy | P | 1.24 | 2,000 | 2,479 | 31,797 | 29.8 K to 31.8 K (+6.71 %) |
| Mar 09 2007 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | EVP Corporate Dev & ... | Option Exercise | A | 4.94 | 48,838 | 241,260 | 48,838 | |
| Mar 09 2007 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | EVP Corporate Dev & ... | Grant | A | 0.00 | 19,562 | 0 | 29,797 | 10.2 K to 29.8 K (+191.13 %) |
| Mar 16 2006 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | EVP Corporate Dev & ... | Option Exercise | A | 1.93 | 200,000 | 386,000 | 200,000 | |
| Mar 16 2006 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | EVP Corporate Dev & ... | Grant | A | 0.00 | 80,000 | 0 | 80,000 | 0 to 80 K |
| Jul 01 2005 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | SVP Corporate Dev & ... | Buy | J | 2.25 | 1,874 | 4,217 | 1,874 | 0 to 1.9 K |
| Jan 05 2005 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | SVP Corporate Dev & ... | Option Exercise | A | 3.60 | 250,000 | 900,000 | 250,000 |
Page: 1